Literature DB >> 15470965

Altered circadian relationship between serum nitric oxide, carbon dioxide, and uric acid in multiple sclerosis.

E L Kanabrocki1, M D Ryan, R C Hermida, D E Ayala, G S Scott, D Murray, W F Bremner, J L H C Third, M C Johnson, S Foley, J Van Cauteren, F Shah, P Shirazi, B A Nemchausky, D C Hooper.   

Abstract

The free radical nitric oxide (NO*) is involved in a variety of diverse biological processes from acting as a vasodilator in the cardiovascular system to being the rate-limiting component in the production of peroxynitrite (ONOO-), a contributor to neurodegenerative disorders such as multiple sclerosis (MS). Uric acid (UA), the end product of purine metabolism in humans and a selective inhibitor of toxic reactions attributed to radicals formed by the interaction of ONOO- and CO2, is generally low in MS patients. We investigated the relationship between serum ONOO-, CO2, and UA in MS patients and normal controls by comparing the circadian characteristics of the NO* metabolites nitrite/ nitrate (NO), CO2, and UA. In this preliminary study, we found the functional relationship ascribed to the circadian timing of the peak and trough levels of NO, CO2, and UA in healthy subjects to be clearly altered in MS patients. These findings suggest that alterations in the temporal relationship between the 24h pattern in serum ONOO- formation and UA may either contribute to or reflect the disease processes in MS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15470965     DOI: 10.1081/cbi-200025981

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  7 in total

1.  Diurnal variations in salivary protein carbonyl levels in normal and cognitively impaired human subjects.

Authors:  Haixiang Su; Mervyn Gornitsky; Guoyan Geng; Ana M Velly; Howard Chertkow; Hyman M Schipper
Journal:  Age (Dordr)       Date:  2008-01-04

2.  Association of circadian rhythm genes ARNTL/BMAL1 and CLOCK with multiple sclerosis.

Authors:  Polona Lavtar; Gorazd Rudolf; Aleš Maver; Alenka Hodžić; Nada Starčević Čizmarević; Maja Živković; Saša Šega Jazbec; Zalika Klemenc Ketiš; Miljenko Kapović; Evica Dinčić; Ranko Raičević; Juraj Sepčić; Luca Lovrečić; Aleksandra Stanković; Smiljana Ristić; Borut Peterlin
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

3.  Xanthine oxidase inhibitors and sepsis.

Authors:  Maria Fátima de Paula Ramos; Alceni do Carmo Morais Monteiro de Barros; Clara Versolato Razvickas; Fernanda T Borges; Nestor Schor
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Jan-Dec       Impact factor: 3.219

4.  Characterizing and Evaluating Diurnal Salivary Uric Acid Across Pregnancy Among Healthy Women.

Authors:  Jenna L Riis; Stephanie H Cook; Nicole Letourneau; Tavis Campbell; Douglas A Granger; Gerald F Giesbrecht
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-18       Impact factor: 5.555

5.  Association of Serum Uric Acid Level With Blood Pressure Variability in Newly Diagnosed Essential Hypertension.

Authors:  Kumral Çağlı; Osman Turak; Uğur Canpolat; Fırat Özcan; Derya Tok; Mehmet Ali Mendi; Fatih Öksüz; Dimitrie Siriopol; Gabriel Veisa; Adrian Covic; Mehmet Kanbay
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-08-07       Impact factor: 3.738

6.  Day/Night and Summer/Winter Changes in Serum Total Antioxidant Capacity.

Authors:  Armando L Morera-Fumero; Pedro Abreu-Gonzalez; Manuel Henry-Benitez; Lourdes Fernandez-Lopez; Estefania Diaz-Mesa; Maria Del Rosario Cejas-Mendez; Fernando Guillen-Pino
Journal:  Med Chem       Date:  2018       Impact factor: 2.745

7.  Relationship between elevated morning blood pressure surge, uric acid, and cardiovascular outcomes in hypertensive patients.

Authors:  Osman Turak; Baris Afsar; Firat Ozcan; Ugur Canpolat; Enis Grbovic; Mehmet Ali Mendi; Fatih Oksuz; Dimitrie Siriopol; Adrian Covic; Mustafa Caliskan; Kim McFann; Richard J Johnson; Mehmet Kanbay
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-06-12       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.